BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26732678)

  • 1. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
    Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
    Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
    Trumpfheller C; Finke JS; López CB; Moran TM; Moltedo B; Soares H; Huang Y; Schlesinger SJ; Park CG; Nussenzweig MC; Granelli-Piperno A; Steinman RM
    J Exp Med; 2006 Mar; 203(3):607-17. PubMed ID: 16505141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
    Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
    J Virol; 2021 May; 95(12):. PubMed ID: 33789991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.
    Trumpfheller C; Longhi MP; Caskey M; Idoyaga J; Bozzacco L; Keler T; Schlesinger SJ; Steinman RM
    J Intern Med; 2012 Feb; 271(2):183-92. PubMed ID: 22126373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.
    Cheong C; Choi JH; Vitale L; He LZ; Trumpfheller C; Bozzacco L; Do Y; Nchinda G; Park SH; Dandamudi DB; Shrestha E; Pack M; Lee HW; Keler T; Steinman RM; Park CG
    Blood; 2010 Nov; 116(19):3828-38. PubMed ID: 20668230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
    J Virol; 2017 May; 91(9):. PubMed ID: 28202751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8
    Ngu LN; Nji NN; Ambada G; Ngoh AA; Njambe Priso GD; Tchadji JC; Lissom A; Magagoum SH; Sake CN; Tchouangueu TF; Chukwuma GO; Okoli AS; Sagnia B; Chukwuanukwu R; Tebit DM; Esimone CO; Waffo AB; Park CG; Überla K; Nchinda GW
    Immun Inflamm Dis; 2018 Mar; 6(1):163-175. PubMed ID: 29205929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor.
    Do Y; Didierlaurent AM; Ryu S; Koh H; Park CG; Park S; Perlin DS; Powell BS; Steinman RM
    Vaccine; 2012 Oct; 30(45):6359-67. PubMed ID: 22947140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
    Ao Z; Wang L; Mendoza EJ; Cheng K; Zhu W; Cohen EA; Fowke K; Qiu X; Kobinger G; Yao X
    PLoS One; 2019; 14(5):e0216949. PubMed ID: 31100082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.
    Mercier GT; Nehete PN; Passeri MF; Nehete BN; Weaver EA; Templeton NS; Schluns K; Buchl SS; Sastry KJ; Barry MA
    Vaccine; 2007 Dec; 25(52):8687-701. PubMed ID: 18063450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
    Flynn BJ; Kastenmüller K; Wille-Reece U; Tomaras GD; Alam M; Lindsay RW; Salazar AM; Perdiguero B; Gomez CE; Wagner R; Esteban M; Park CG; Trumpfheller C; Keler T; Pantaleo G; Steinman RM; Seder R
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7131-6. PubMed ID: 21467219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4
    Ngu LN; Nji NN; Ambada GE; Sagnia B; Sake CN; Tchadji JC; Njambe Priso GD; Lissom A; Tchouangueu TF; Manga Tebit D; Waffo AB; Park CG; Steinman RM; Überla K; Nchinda GW
    Immun Inflamm Dis; 2019 Jun; 7(2):55-67. PubMed ID: 28474788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.
    Roshorm Y; Hong JP; Kobayashi N; McMichael AJ; Volsky DJ; Potash MJ; Takiguchi M; Hanke T
    Eur J Immunol; 2009 Jul; 39(7):1831-40. PubMed ID: 19585509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.
    Chege GK; Burgers WA; Stutz H; Meyers AE; Chapman R; Kiravu A; Bunjun R; Shephard EG; Jacobs WR; Rybicki EP; Williamson AL
    J Virol; 2013 May; 87(9):5151-60. PubMed ID: 23449790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.